hydroxysteroid 17-beta dehydrogenase 4
| UniProt | Protein Name |
|---|---|
| B3KSP2 |
|
| B2R659 |
|
| A0A0S2Z4J1 |
|
| P51659 |
|
| E7ET17 |
|
| A0A804HK65 |
|
| A0A2R8Y7L2 |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| very long-chain fatty acid metabolic process |
|
|
| osteoblast differentiation | ||
| fatty acid biosynthetic process | ||
| fatty acid beta-oxidation | ||
| fatty acid beta-oxidation |
| GO Term | Evidence Code | PMID |
|---|---|---|
| peroxisome | ||
| peroxisome | ||
| peroxisome | ||
| peroxisome | ||
| peroxisomal membrane |
| GO Term | Evidence Code | PMID |
|---|---|---|
| (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity | ||
| enoyl-CoA hydratase activity | ||
| estradiol 17-beta-dehydrogenase [NAD(P)+] activity | ||
| oxidoreductase activity |
|
|
| oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
| Gene Ontology |
|---|
| fatty acid beta-oxidation |
| lipid metabolic process |
| oxidoreductase activity |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0050857 | Perrault syndrome | |
| DOID:0090031 | D-bifunctional protein deficiency | |
| DOID:13366 | Stiff-Person syndrome |
| HPO ID | HPO Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000107 | Renal cyst |
| HP:0000133 | Gonadal dysgenesis |
| HP:0000218 | High palate |
| HP:0000239 | Large fontanelles |
| HP:0000256 | Macrocephaly |
| HP:0000268 | Dolichocephaly |
| HP:0000270 | Delayed cranial suture closure |
| HP:0000278 | Retrognathia |
| HP:0000286 | Epicanthus |
| Disease ID | Disease Name |
|---|---|
| OMIM:233400 |
|
| OMIM:261515 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026